[Official guidelines for the treatment of acute mania].
There are several national and international practice guidelines on the treatment of acute mania. Their purpose is to assess the available evidence of efficacy for medication used in the treatment of bipolar mania and to grade it according to the quality of studies available. The World Federation of Societies of Biological Psychiatry (WFSBP) has developed such guidelines in 2003. They categorize the scientific quality of the studies into four levels of evidence (A-D) and provide an algorithm based on the degree of severity of the acute manic episode.
Krüger
Stephanie
S
Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universitätsklinik Carl-Gustav Carus, Dresden.
Bräunig
Peter
P
Grunze
Heinz
H
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000465:Algorithms; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D064420:Drug-Related Side Effects and Adverse Reactions; D005059:Euphoria / Q000187:drug effects; D019317:Evidence-Based Medicine; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged
D018692:Antimanic Agents